FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2107178532> ?p ?o ?g. }

• W2107178532 endingPage "1253" @default.
• W2107178532 startingPage "1243" @default.
• W2107178532 abstract "Objective:To demonstrate that a fixed-dose combination of enteric-coated naproxen 500 mg and immediate-release esomeprazole magnesium 20 mg has comparable efficacy to celecoxib for knee osteoarthritis.Research design and methods:Two randomized, double-blind, parallel-group, placebo-controlled, multicenter phase III studies (PN400-307 and PN400-309) enrolled patients aged ≥50 years with symptomatic knee osteoarthritis. Following an osteoarthritis flare, patients received naproxen/esomeprazole magnesium twice daily, celecoxib 200 mg once daily, or placebo for 12 weeks.Clinical trial registration:NCT00664560 and NCT00665431.Main outcome measures:Three co-primary efficacy endpoints were mean change from baseline to week 12 in Western Ontario and McMaster Osteoarthritis Index (WOMAC) pain and function subscales, and Patient Global Assessment of osteoarthritis using a visual analog scale (PGA-VAS).Results:In Study 307, 619 patients were randomized and 614 treated. In Study 309, 615 patients were randomized and 610 treated. Both naproxen/esomeprazole magnesium and celecoxib were associated with improvements (least squares mean change from baseline to week 12) in WOMAC pain (Study 307: −42.0 and −41.8, respectively; Study 309: −44.2 and −42.9, respectively), WOMAC function (Study 307: −36.4 and −36.3, respectively; Study 309: −38.9 and −36.8, respectively), and PGA-VAS (Study 307: 21.2 and 21.6, respectively; Study 309: 29.0 and 25.6, respectively). A prespecified non-inferiority margin of 10 mm between naproxen/esomeprazole magnesium and celecoxib was satisfied for each co-primary endpoint at week 12 in both studies. Significant improvements were observed with naproxen/esomeprazole magnesium versus placebo in both studies (p < 0.05). Celecoxib was significantly different from placebo in Study 307 (p < 0.05); however, the improvements were not significant in Study 309. Acetaminophen use and patient expectation of receiving active treatment (80% probability) may have contributed to a high placebo response observed.Conclusions:Naproxen/esomeprazole magnesium has comparable efficacy to celecoxib for the management of pain associated with osteoarthritis of the knee over 12 weeks." @default.
• W2107178532 created "2016-06-24" @default.
• W2107178532 creator A5004421589 @default.
• W2107178532 creator A5018989715 @default.
• W2107178532 creator A5026165132 @default.
• W2107178532 creator A5046574969 @default.
• W2107178532 creator A5047806708 @default.
• W2107178532 date "2011-04-28" @default.
• W2107178532 modified "2023-09-26" @default.
• W2107178532 title "Fixed-dose combination of enteric-coated naproxen and immediate-release esomeprazole has comparable efficacy to celecoxib for knee osteoarthritis: two randomized trials" @default.
• W2107178532 cites W1495208365 @default.
• W2107178532 cites W1878493504 @default.
• W2107178532 cites W1969798546 @default.
• W2107178532 cites W1972368489 @default.
• W2107178532 cites W1980913979 @default.
• W2107178532 cites W1983104516 @default.
• W2107178532 cites W1985247069 @default.
• W2107178532 cites W1988145586 @default.
• W2107178532 cites W1990824360 @default.
• W2107178532 cites W2004718890 @default.
• W2107178532 cites W2010673118 @default.
• W2107178532 cites W2012920835 @default.
• W2107178532 cites W2013018458 @default.
• W2107178532 cites W2022672351 @default.
• W2107178532 cites W2027698993 @default.
• W2107178532 cites W2040872866 @default.
• W2107178532 cites W2041998517 @default.
• W2107178532 cites W2055841596 @default.
• W2107178532 cites W2058147305 @default.
• W2107178532 cites W2078909311 @default.
• W2107178532 cites W2080195990 @default.
• W2107178532 cites W2084863173 @default.
• W2107178532 cites W2117896603 @default.
• W2107178532 cites W2130513475 @default.
• W2107178532 cites W2133241284 @default.
• W2107178532 cites W2133278537 @default.
• W2107178532 cites W2135956897 @default.
• W2107178532 cites W2139295271 @default.
• W2107178532 cites W2145218953 @default.
• W2107178532 cites W2158131645 @default.
• W2107178532 cites W2160685542 @default.
• W2107178532 cites W2167792025 @default.
• W2107178532 cites W2330496155 @default.
• W2107178532 cites W2610860323 @default.
• W2107178532 cites W2978946127 @default.
• W2107178532 cites W4211049951 @default.
• W2107178532 cites W4248226706 @default.
• W2107178532 doi "https://doi.org/10.1185/03007995.2011.580340" @default.
• W2107178532 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21524238" @default.
• W2107178532 hasPublicationYear "2011" @default.
• W2107178532 type Work @default.
• W2107178532 sameAs 2107178532 @default.
• W2107178532 citedByCount "48" @default.
• W2107178532 countsByYear W21071785322012 @default.
• W2107178532 countsByYear W21071785322013 @default.
• W2107178532 countsByYear W21071785322014 @default.
• W2107178532 countsByYear W21071785322015 @default.
• W2107178532 countsByYear W21071785322016 @default.
• W2107178532 countsByYear W21071785322017 @default.
• W2107178532 countsByYear W21071785322018 @default.
• W2107178532 countsByYear W21071785322020 @default.
• W2107178532 countsByYear W21071785322021 @default.
• W2107178532 countsByYear W21071785322022 @default.
• W2107178532 countsByYear W21071785322023 @default.
• W2107178532 crossrefType "journal-article" @default.
• W2107178532 hasAuthorship W2107178532A5004421589 @default.
• W2107178532 hasAuthorship W2107178532A5018989715 @default.
• W2107178532 hasAuthorship W2107178532A5026165132 @default.
• W2107178532 hasAuthorship W2107178532A5046574969 @default.
• W2107178532 hasAuthorship W2107178532A5047806708 @default.
• W2107178532 hasConcept C126322002 @default.
• W2107178532 hasConcept C14184104 @default.
• W2107178532 hasConcept C142724271 @default.
• W2107178532 hasConcept C168563851 @default.
• W2107178532 hasConcept C203092338 @default.
• W2107178532 hasConcept C204787440 @default.
• W2107178532 hasConcept C27081682 @default.
• W2107178532 hasConcept C2776164576 @default.
• W2107178532 hasConcept C2776467144 @default.
• W2107178532 hasConcept C2778115740 @default.
• W2107178532 hasConcept C2778139025 @default.
• W2107178532 hasConcept C2778204628 @default.
• W2107178532 hasConcept C2779286237 @default.
• W2107178532 hasConcept C42219234 @default.
• W2107178532 hasConcept C71924100 @default.
• W2107178532 hasConceptScore W2107178532C126322002 @default.
• W2107178532 hasConceptScore W2107178532C14184104 @default.
• W2107178532 hasConceptScore W2107178532C142724271 @default.
• W2107178532 hasConceptScore W2107178532C168563851 @default.
• W2107178532 hasConceptScore W2107178532C203092338 @default.
• W2107178532 hasConceptScore W2107178532C204787440 @default.
• W2107178532 hasConceptScore W2107178532C27081682 @default.
• W2107178532 hasConceptScore W2107178532C2776164576 @default.
• W2107178532 hasConceptScore W2107178532C2776467144 @default.
• W2107178532 hasConceptScore W2107178532C2778115740 @default.
• W2107178532 hasConceptScore W2107178532C2778139025 @default.
• W2107178532 hasConceptScore W2107178532C2778204628 @default.
• W2107178532 hasConceptScore W2107178532C2779286237 @default.

• next